Pharmacyclics LLC, an AbbVie company, will host a presentation on IMBRUVICA® (ibrutinib) during the ASH Annual Meeting.

Pharmacyclics LLC, invites you to attend a Multidisciplinary Discussion during the 2022 ASH Annual Meeting on Incorporating Imbruvica® (ibrutinib) into treatment strategies.   The program will be held on Monday December 12th from 8:00 to 9:00 AM in Exhibit Hall/Theater 7 during the ASH Annual Meeting.  Session sponsored by Pharmacyclics LLC, an AbbVie company and Janssen Biotech, Inc.

Please note: Your e-mail address is required for registration. The information you provide will only be used to facilitate your attendance at this program.

No comments have been posted yet.